What does CUSIP 09061G101 represent in this 13F holders report?

CUSIP 09061G101 is the security identifier for BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock used to aggregate holder disclosures.

How many institutions held BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock in Q2 2020?

516 institutional investors reported BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock for Q2 2020. Use the holders table for investor-level position and value details.

BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)

CUSIP: 09061G101

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock
Shares outstanding: 192,975,286
Total 13F shares: 180,885,676
Share change: +4,136,442
Total reported value: $22,304,634,235
Put/Call ratio: 79%
Price per share: $123.34
Number of holders: 516
Value change: +$749,303,824
Number of buys: 288
Number of sells: 221

Quarterly Holders Quick Answers

What is CUSIP 09061G101?
CUSIP 09061G101 identifies BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 09061G101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Capital Research Global Investors	13F	Company	11%	22,040,618	$1,862,430,000	—	31 Mar 2020	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	9.2%	17,809,767	$1,504,925,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	8.8%	16,956,050	$1,432,786,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	7.6%	14,595,710	$1,233,338,000	—	31 Mar 2020	13F
JENNISON ASSOCIATES LLC	13F	Company	4.3%	8,214,463	$694,122,000	—	31 Mar 2020	13F
BAKER BROS. ADVISORS LP	13F	Company	3.9%	7,589,294	$641,295,000	—	31 Mar 2020	13F
Clearbridge Investments, LLC	13F	Company	3.3%	6,313,702	$533,508,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	2.9%	5,539,545	$468,092,000	—	31 Mar 2020	13F
DODGE & COX	13F	Company	2%	3,942,508	$333,142,000	—	31 Mar 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	1.6%	2,998,136	$253,271,000	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	1.4%	2,615,010	$220,968,000	—	31 Mar 2020	13F
Temasek Holdings (Private) Ltd	13F	Company	1.2%	2,372,712	$200,494,000	—	31 Mar 2020	13F
Winslow Capital Management, LLC	13F	Company	1.1%	2,150,822	$181,745,000	—	31 Mar 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	1.1%	2,098,581	$177,329,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.1%	2,082,293	$175,805,000	—	31 Mar 2020	13F
Avoro Capital Advisors LLC	13F	Company	1%	1,930,000	$163,085,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.94%	1,819,574	$153,754,000	—	31 Mar 2020	13F
FMR LLC	13F	Company	0.9%	1,736,324	$146,719,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.87%	1,682,507	$142,172,000	—	31 Mar 2020	13F
NORGES BANK	13F	Company	0.8%	1,553,298	$131,254,000	—	31 Mar 2020	13F
Palo Alto Investors LP	13F	Company	0.8%	1,544,163	$130,482,000	—	31 Mar 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.77%	1,483,313	$125,343,000	—	31 Mar 2020	13F
VIKING GLOBAL INVESTORS LP	13F	Company	0.75%	1,453,625	$122,831,000	—	31 Mar 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.73%	1,413,908	$119,475,000	—	31 Mar 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.68%	1,306,188	$110,372,890	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	0.63%	1,222,203	$103,275,000	—	31 Mar 2020	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.59%	1,132,079	$95,660,000	—	31 Mar 2020	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.57%	1,108,304	$93,651,000	—	31 Mar 2020	13F
Manning & Napier Group, LLC	13F	Company	0.54%	1,050,358	$88,754,000	—	31 Mar 2020	13F
Legal & General Group Plc	13F	Company	0.53%	1,025,778	$86,674,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.53%	1,019,083	$86,113,000	—	31 Mar 2020	13F
FRONTIER CAPITAL MANAGEMENT CO LLC	13F	Company	0.51%	982,596	$83,029,000	—	31 Mar 2020	13F
Capital International Investors	13F	Company	0.5%	973,529	$82,263,000	—	31 Mar 2020	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.44%	855,001	$72,247,000	—	31 Mar 2020	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	0.43%	838,657	$70,867,000	—	31 Mar 2020	13F
USS Investment Management Ltd	13F	Company	0.42%	816,603	$68,983,000	—	31 Mar 2020	13F
FIRST TRUST ADVISORS LP	13F	Company	0.39%	756,998	$63,966,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	0.39%	748,900	$63,282,000	—	31 Mar 2020	13F
TCW GROUP INC	13F	Company	0.38%	738,377	$62,393,000	—	31 Mar 2020	13F
Marshall Wace North America L.P.	13F	Company	0.38%	727,758	$61,495,000	—	31 Mar 2020	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	0.37%	714,335	$60,361,000	—	31 Mar 2020	13F
Swiss National Bank	13F	Company	0.36%	697,132	$58,908,000	—	31 Mar 2020	13F
LOOMIS SAYLES & CO L P	13F	Company	0.33%	644,072	$54,424,000	—	31 Mar 2020	13F
ZEVENBERGEN CAPITAL INVESTMENTS LLC	13F	Company	0.33%	643,125	$54,344,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.31%	596,631	$50,416,000	—	31 Mar 2020	13F
MORGAN STANLEY	13F	Company	0.28%	546,740	$46,199,000	—	31 Mar 2020	13F
CARILLON TOWER ADVISERS, INC.	13F	Company	0.28%	547,600	$45,971,854	—	31 Mar 2020	13F
ORBIMED ADVISORS LLC	13F	Company	0.28%	540,500	$45,672,000	—	31 Mar 2020	13F
Invesco Ltd.	13F	Company	0.27%	528,140	$44,627,000	—	31 Mar 2020	13F
SAMLYN CAPITAL, LLC	13F	Company	0.27%	521,079	$44,031,000	—	31 Mar 2020	13F

Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q2 2020

As of 30 Jun 2020, BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) was held by 516 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 180,885,676 shares. The largest 10 holders included Capital Research Global Investors, PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, BlackRock Inc., JENNISON ASSOCIATES LLC, BAKER BROS. ADVISORS LP, Clearbridge Investments, LLC, STATE STREET CORP, Dodge & Cox, and AMERIPRISE FINANCIAL INC. This page lists 517 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

489

Q2 2020 holders

516

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.